Thursday’s insider activity: Major buys and sells disclosed

Here’s a roundup of the most significant insider trading activity disclosed on Thursday for US-listed companies.

Top insider buys

Expensify, Inc. saw substantial buying activity from Steven J. McLaughlin, a director and 10% owner, who acquired Class A Common Stock totaling $988,745 over three consecutive days in November 2026. On November 9, 2026, Mr. McLaughlin acquired 181,553 shares at a weighted average price of $1.853, with actual prices ranging from $1.785 to $1.90. The following day, he acquired an additional 196,809 shares at a weighted average price of $1.693, with prices ranging from $1.655 to $1.81. On November 11, Mr. McLaughlin purchased 179,186 shares at a weighted average price of $1.781, with individual transaction prices ranging from $1.71 to $1.81. The buying spree came as the stock traded at $1.86, down 9.3% over the past week, though shares have surged 63% over the past six months. According to InvestingPro analysis, the stock appears undervalued at current levels, landing it on the platform’s most undervalued stocks list.

Hudson Pacific Properties, Inc. director Jon E. Bortz increased his holdings in the company through several stock purchases totaling $680,112 across multiple transactions between November 9 and November 11, 2026. The shares were purchased at prices ranging from $8.76 to $9.5 per share. Following these acquisitions, Mr. Bortz’s direct beneficial ownership in Hudson Pacific Properties stands at 110,394 shares of common stock. The insider buying comes as HPP trades at $8.80, down nearly 39% over the past year. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value assessment, placing it among undervalued opportunities in the market. The company trades at a Price/Book ratio of just 0.22, significantly below typical market multiples. InvestingPro offers 14 additional exclusive tips for HPP investors seeking deeper insights.

Bloomin’ Brands, Inc. CEO and Director Mike Spanos acquired 50,000 shares of the company’s common stock on November 11, 2026, for a total value of approximately $501,999. The shares were bought at an average weighted price of $10.04, with individual purchases occurring at varying prices within a range of $9.70 to $10.25 per share.

Brookdale Senior Living Inc. director C. Christian Winkle purchased 40,000 shares of the company’s common stock for a total value of $358,068. The transactions, which occurred on November 10, 2026, were executed at prices ranging from $8.935 to $8.96 per share, with an average purchase price of $8.9517. Following these acquisitions, Mr. Winkle indirectly holds 40,000 shares of Brookdale Senior Living common stock through The Charles C. Winkle Revocable Trust. The purchase comes as the stock trades near its 52-week low of $8.79, down 48% from its 52-week high of $17.09. According to InvestingPro analysis, the company currently appears overvalued relative to its Fair Value estimate. Wall Street analysts remain optimistic, setting price targets between $12 and $21 per share. For deeper insights into BKD’s valuation and growth prospects, investors can access the comprehensive Pro Research Report, available for this and 1,400+ other US equities on InvestingPro.

Matador Resources Co chairman and chief executive officer Joseph Wm Foran recently increased his direct stake in the company through a stock purchase on November 10, 2026. Mr. Foran acquired 2,500 shares of common stock for a total value of $123,225. The shares were purchased at a weighted average price of $49.29 per share, with individual transaction prices ranging from $49.29 to $49.30. This acquisition was made pursuant to the company’s Employee Stock Purchase Plan. The stock currently trades at $52.81, up 28% year-to-date, and InvestingPro analysis indicates the company remains undervalued, suggesting further upside potential for shareholders.

Top insider sells

Hagerty, Inc. saw Hagerty Holding Corp., a director and 10% owner, sell 11,500,000 shares of the company’s Class A common stock for a total value of $164,795,000. The transactions occurred on November 10 and November 12, 2026, with all shares sold at a price of $14.33 each. The sales followed the conversion of Paired Interests into Class A common stock. On November 10, Hagerty Holding Corp. acquired 10,000,000 shares of Class A common stock by exchanging an equal number of Paired Interests. Each Paired Interest consists of one share of Class V Common Stock of Hagerty and one unit of limited liability company interest of The Hagerty Group, LLC (OpCo). This exchange was conducted under the terms of an Amended and Restated Exchange Agreement. Immediately after this acquisition, the entity sold all 10,000,000 Class A common shares. The sale price came as the stock has declined roughly 14% over the past week, though shares currently trade at $15.80, reflecting the company’s 58% surge over the past six months. Despite the insider sale, InvestingPro analysis suggests Hagerty remains undervalued relative to its Fair Value, with the company maintaining a "GOOD" financial health score. The specialty insurance provider trades at a market capitalization of $5.51 billion.

Liberty Media Corp director Chase Carey sold 579,331 shares of Series C Common Stock for a total of $62,125,764 between November 9 and November 12, 2026. The shares were sold at prices ranging from $105.1259 to $110.6048. These sales followed Mr. Carey’s exercise of stock options to acquire 574,331 shares of Series C Common Stock during the same period. He acquired these shares at an exercise price of $28.00 per share, totaling $16,081,268.

Centuri Holdings, Inc. director and 10% owner Carl C. Icahn sold a total of 1,500,433 shares of the company’s common stock for approximately $30.1 million over several days in November. The transactions took place between November 9 and November 12, 2026, with prices ranging from $17.50 to $21.00 per share. On November 9, 2026, Mr. Icahn disposed of 625,570 shares at a price of $21.00 per share. The following day, November 10, he sold an additional 374,430 shares, also at $21.00 each. Further sales included 175,733 shares on November 11 at $19.72 per share, and 324,700 shares on November 12 at $17.50 per share. The stock currently trades at $22.25, showing a 9.2% gain over the past week, though it remains down 31% over six months. According to InvestingPro analysis, the stock appears undervalued at current levels, with a market cap of $2.25 billion.

Hinge Health, Inc. Executive Chairman and Co-Founder Gabriel M.I. Mecklenburg sold 200,000 shares of the company’s Class A Common Stock on November 11, 2026. The transactions, executed as part of a pre-arranged trading plan, totaled approximately $24.5 million, with share prices ranging from $121.28 to $125.57. The sales followed Mecklenburg’s acquisition of 200,000 shares of Class A Common Stock at a price of $0 per share on the same date. These shares were obtained through the conversion of Class B Common Stock, which is convertible into Class A Common Stock at the holder’s election or upon certain events. The disposals were carried out under a Rule 10b5-1 trading plan, which Mecklenburg adopted on June 12, 2026. The sale came as the stock trades near its 52-week high of $126.40, following a remarkable 190% return over the past year. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value, placing it among companies on the most overvalued list.

Neptune Insurance Holdings Inc. President and Chief Risk Officer Matthew Paul Duffy sold a total of 260,000 shares of the company’s Class A Common Stock across three transactions in early November 2026, totaling approximately $7.31 million. The sales occurred between November 9 and November 11, with weighted average prices ranging from $28.0295 to $28.2784 per share. On November 9, 2026, Mr. Duffy disposed of 88,000 shares at a weighted average price of $28.0295. These shares were sold in multiple transactions at prices ranging from $27.88 to $28.205.

Monitoring insider trading activity can provide valuable insights into how company executives and major shareholders view their stock’s prospects. While insider purchases may signal confidence in a company’s future performance, and sales might suggest the opposite, it’s important to remember that insiders sell for various reasons, including portfolio diversification and personal financial planning. Investors should consider insider transactions as one of many factors when making investment decisions, rather than relying on them exclusively.